DE60231625D1 - Systeme und verfahren zum screening pharmazeutischer chemikalien - Google Patents

Systeme und verfahren zum screening pharmazeutischer chemikalien

Info

Publication number
DE60231625D1
DE60231625D1 DE60231625T DE60231625T DE60231625D1 DE 60231625 D1 DE60231625 D1 DE 60231625D1 DE 60231625 T DE60231625 T DE 60231625T DE 60231625 T DE60231625 T DE 60231625T DE 60231625 D1 DE60231625 D1 DE 60231625D1
Authority
DE
Germany
Prior art keywords
systems
model system
pharmaceutical chemicals
activator
tissue model
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60231625T
Other languages
English (en)
Inventor
Elliot Elson
William B Mcconnaughey
Tetsuro Wakatsuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
St Louis University
Washington University in St Louis WUSTL
Original Assignee
St Louis University
Washington University in St Louis WUSTL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St Louis University, Washington University in St Louis WUSTL filed Critical St Louis University
Application granted granted Critical
Publication of DE60231625D1 publication Critical patent/DE60231625D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5061—Muscle cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N3/00—Investigating strength properties of solid materials by application of mechanical stress
    • G01N3/32—Investigating strength properties of solid materials by application of mechanical stress by applying repeated or pulsating forces
    • G01N3/38—Investigating strength properties of solid materials by application of mechanical stress by applying repeated or pulsating forces generated by electromagnetic means
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5064—Endothelial cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2203/00—Investigating strength properties of solid materials by application of mechanical stress
    • G01N2203/0001—Type of application of the stress
    • G01N2203/0005—Repeated or cyclic
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2203/00—Investigating strength properties of solid materials by application of mechanical stress
    • G01N2203/0014—Type of force applied
    • G01N2203/0016—Tensile or compressive
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2203/00—Investigating strength properties of solid materials by application of mechanical stress
    • G01N2203/0058—Kind of property studied
    • G01N2203/0069—Fatigue, creep, strain-stress relations or elastic constants
    • G01N2203/0073—Fatigue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2203/00—Investigating strength properties of solid materials by application of mechanical stress
    • G01N2203/02—Details not specific for a particular testing method
    • G01N2203/026—Specifications of the specimen
    • G01N2203/0262—Shape of the specimen
    • G01N2203/0278—Thin specimens
    • G01N2203/0282—Two dimensional, e.g. tapes, webs, sheets, strips, disks or membranes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Electromagnetism (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
DE60231625T 2001-08-14 2002-08-14 Systeme und verfahren zum screening pharmazeutischer chemikalien Expired - Lifetime DE60231625D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31232201P 2001-08-14 2001-08-14
PCT/US2002/025761 WO2003016860A2 (en) 2001-08-14 2002-08-14 Systems and methods for screening pharmaceutical chemicals

Publications (1)

Publication Number Publication Date
DE60231625D1 true DE60231625D1 (de) 2009-04-30

Family

ID=23210916

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60231625T Expired - Lifetime DE60231625D1 (de) 2001-08-14 2002-08-14 Systeme und verfahren zum screening pharmazeutischer chemikalien

Country Status (8)

Country Link
US (2) US7449306B2 (de)
EP (2) EP1425385B1 (de)
JP (1) JP4638146B2 (de)
AT (1) ATE426015T1 (de)
AU (1) AU2002356043A1 (de)
CA (1) CA2497343C (de)
DE (1) DE60231625D1 (de)
WO (1) WO2003016860A2 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8227240B2 (en) 2001-08-14 2012-07-24 The Washington University Systems for screening pharmaceutical chemicals
EP1425385B1 (de) 2001-08-14 2009-03-18 Washington University in St. Louis Systeme und verfahren zum screening pharmazeutischer chemikalien
US7348175B2 (en) * 2002-03-15 2008-03-25 St3 Development Corporation Bioreactor with plurality of chambers for conditioning intravascular tissue engineered medical products
US7497864B2 (en) * 2003-04-30 2009-03-03 Marctec, Llc. Tissue fastener and methods for using same
EP2578676A1 (de) * 2003-06-20 2013-04-10 Axiogenesis Ag Formgebung zu Gewebe in einem embryonischen Stammzellen (ES) System
US7738682B2 (en) * 2003-10-22 2010-06-15 Medtrain Technologies, Llc Tissue engineered construct analytical imaging system and method of obtaining and analyzing images of tissue engineered constructs
WO2005098425A1 (en) 2004-04-07 2005-10-20 Axiogenesis Ag Non-invasive, in vitro functional tissue assay systems
EP3070174B1 (de) 2004-05-11 2019-11-06 Ncardia AG Medikamentenaufspürung auf der basis von in vitro differenzierten zellen
KR100665299B1 (ko) * 2004-06-10 2007-01-04 서울반도체 주식회사 발광물질
WO2006044997A2 (en) * 2004-10-15 2006-04-27 The Trustees Of Columbia University In The City Of New York System and method for localized measurement and imaging of viscosity of tissues
US8858441B2 (en) * 2005-05-12 2014-10-14 The Trustees Of Columbia University In The City Of New York System and method for electromechanical wave imaging of body structures
US10687785B2 (en) 2005-05-12 2020-06-23 The Trustees Of Columbia Univeristy In The City Of New York System and method for electromechanical activation of arrhythmias
US20080025917A1 (en) * 2006-04-10 2008-01-31 Malcolm Whitman Methods for modulating formation and progression of cellulite
WO2008027520A2 (en) * 2006-08-30 2008-03-06 The Trustees Of Columbia University In The City Of New York Systems and methods for composite elastography and wave imaging
JP4931017B2 (ja) * 2008-01-10 2012-05-16 国立大学法人山口大学 細胞への伸展刺激負荷デバイス
WO2011035312A1 (en) 2009-09-21 2011-03-24 The Trustees Of Culumbia University In The City Of New York Systems and methods for opening of a tissue barrier
CN107267384B (zh) * 2008-06-05 2020-11-27 因维沃科学有限公司 用于高通量试验的三维组织
WO2010014977A1 (en) * 2008-08-01 2010-02-04 The Trustees Of Columbia University In The City Of New York Systems and methods for matching and imaging tissue characteristics
AU2009282480B2 (en) 2008-08-11 2015-05-07 Children's Medical Center Corporation Halofuginone analogs for inhibition of tRNA synthetases and uses thereof
WO2010030819A1 (en) 2008-09-10 2010-03-18 The Trustees Of Columbia University In The City Of New York Systems and methods for opening a tissue
JP2015037381A (ja) * 2009-03-18 2015-02-26 株式会社豊田中央研究所 筋細胞の出力装置及び筋細胞の出力評価方法
WO2011137210A2 (en) * 2010-04-30 2011-11-03 The Regents Of The University Of California Modulating compliance of trabecular meshwork
JP5549547B2 (ja) * 2010-11-04 2014-07-16 株式会社豊田中央研究所 筋細胞の出力装置及び筋細胞の出力評価方法
US9320491B2 (en) 2011-04-18 2016-04-26 The Trustees Of Columbia University In The City Of New York Ultrasound devices methods and systems
WO2012162664A1 (en) 2011-05-26 2012-11-29 The Trustees Of Columbia University In The City Of New York Systems and methods for opening of a tissue barrier in primates
WO2012170490A2 (en) 2011-06-06 2012-12-13 Invivosciences, Llc Engineered cardiac tissues and methods of using them
JP2015506363A (ja) 2012-01-13 2015-03-02 プレジデント アンド フェローズ オブ ハーバード カレッジ ハロフジノール誘導体、および化粧料組成物および医薬組成物におけるその使用
WO2014059170A1 (en) 2012-10-10 2014-04-17 The Trustees Of Columbia University In The City Of New York Systems and methods for mechanical mapping of cardiac rhythm
US9247921B2 (en) 2013-06-07 2016-02-02 The Trustees Of Columbia University In The City Of New York Systems and methods of high frame rate streaming for treatment monitoring
US10322178B2 (en) 2013-08-09 2019-06-18 The Trustees Of Columbia University In The City Of New York Systems and methods for targeted drug delivery
US10028723B2 (en) 2013-09-03 2018-07-24 The Trustees Of Columbia University In The City Of New York Systems and methods for real-time, transcranial monitoring of blood-brain barrier opening
EP3063262A4 (de) * 2013-10-30 2017-07-19 Miklas, Jason Vorrichtungen und verfahren für eine dreidimensionale gewebekultur
AU2016331079B2 (en) * 2015-10-02 2022-07-14 Wake Forest University Health Sciences Spontaneously beating cardiac organoid constructs and integrated body-on-chip apparatus containing the same
DE102016110328B3 (de) * 2016-06-03 2017-09-07 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Lochplatte
FR3064359B1 (fr) * 2017-03-21 2021-04-16 Centre Nat Rech Scient Dispositif pour la caracterisation mecanique d'un element d'interet par exemple un ovocyte
US20180372724A1 (en) * 2017-06-26 2018-12-27 The Regents Of The University Of California Methods and apparatuses for prediction of mechanism of activity of compounds
WO2019237125A1 (en) 2018-06-08 2019-12-12 The General Hospital Corporation Inhibitors of prolyl-trna-synthetase

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US526357A (en) * 1894-09-18 Antirust-ware
US4593042A (en) * 1985-10-18 1986-06-03 G. D. Searle & Co. Bicyclo-substituted phenylacetonitrile derivatives
US4705785A (en) * 1986-04-09 1987-11-10 Ortho Pharmaceutical Corporation Substituted thiacycloalkeno (3,2-b) pyridines and pharmaceutical compositions and method of use
US4839280A (en) * 1987-05-04 1989-06-13 Banes Albert J Apparatus for applying stress to cell cultures
US5038795A (en) * 1987-08-05 1991-08-13 Roush Elsie S Muscle tonometer apparatus and method
US5464853A (en) * 1993-05-20 1995-11-07 Immunopharmaceutics, Inc. N-(5-isoxazolyl)biphenylsulfonamides, N-(3-isoxazolyl)biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
US5122470A (en) * 1988-07-05 1992-06-16 Banes Albert J Floating cell culture device and method
US4940853A (en) * 1988-07-22 1990-07-10 Vandenburgh Herman H Method for growing tissue specimens in vitro
US4940856A (en) * 1989-06-26 1990-07-10 Burndy Corporation Electrical connector
US5326357A (en) * 1992-03-18 1994-07-05 Mount Sinai Hospital Corporation Reconstituted cartridge tissue
US5486457A (en) * 1993-08-25 1996-01-23 Children's Medical Center Corporation Method and system for measurement of mechanical properties of molecules and cells
US5571083A (en) * 1994-02-18 1996-11-05 Lemelson; Jerome H. Method and system for cell transplantation
DE19500498C2 (de) 1995-01-10 1997-05-07 Thomas Dr Med Eschenhagen Matrixkörper für die Messung isometrischer Kraftparameter von Zellgewebe, Verfahren zum Herstellen des Matrixkörpers, Set für dieses Verfahren und Verwendung des Matrixkörpers zum Kultivieren von Kardiomyozyten
AU7377396A (en) * 1995-09-27 1997-04-17 Artann Laboratories Measuring anisotropic mechanical properties of tissue
US5665391A (en) * 1995-10-12 1997-09-09 Spectral Diagnostics Inc. Cultured, full-thickness integument substitutes based on three-dimensional matrix membranes
US20060105357A1 (en) * 1998-02-18 2006-05-18 Myomics, Inc. Tissue sensor and uses thereof
DE69903800T2 (de) * 1998-03-18 2003-10-02 Massachusetts Inst Technology Vaskularisierte perfundierte anordnungen für mikrogewebe und mikroorgane
CA2306275C (en) * 1999-04-23 2009-11-03 Bio Syntech Canada Inc. Universal mechanical testing device
AU783432B2 (en) 1999-06-25 2005-10-27 Genetronics, Inc. High efficiency transfection based on low electric field strength, long pulse length
DE10003521A1 (de) * 2000-01-27 2001-08-09 Medigene Ag Vorrichtung zum Herstellen eines dreidimensionalen Matrixkörpers, Multi-Well-Platte, Lösung zum Kultivieren von Säugerkardiomyocyten, Verfahren zum Kultivieren einer Zellkultur, Vorrichtung für die Messung isometrischer Kraftparameter von Zellkulturen sowie Verfahren zum meßbaren Verfolgen von Kontraktionen eines in eine Trägersubstanz eingelagerten Zellgewebes
US8227240B2 (en) * 2001-08-14 2012-07-24 The Washington University Systems for screening pharmaceutical chemicals
EP1425385B1 (de) * 2001-08-14 2009-03-18 Washington University in St. Louis Systeme und verfahren zum screening pharmazeutischer chemikalien

Also Published As

Publication number Publication date
EP1983043A1 (de) 2008-10-22
US8071381B2 (en) 2011-12-06
JP4638146B2 (ja) 2011-02-23
EP1425385B1 (de) 2009-03-18
US7449306B2 (en) 2008-11-11
EP1425385A4 (de) 2005-04-06
US20090068701A1 (en) 2009-03-12
WO2003016860A3 (en) 2003-06-12
CA2497343C (en) 2013-04-02
AU2002356043A1 (en) 2003-03-03
EP1425385A2 (de) 2004-06-09
CA2497343A1 (en) 2003-02-27
WO2003016860A2 (en) 2003-02-27
ATE426015T1 (de) 2009-04-15
JP2005523417A (ja) 2005-08-04
US20030064358A1 (en) 2003-04-03

Similar Documents

Publication Publication Date Title
DE60231625D1 (de) Systeme und verfahren zum screening pharmazeutischer chemikalien
DE60238202D1 (de) Verfahren und vorrichtung zur kalibrierung von sensoren
ATE381706T1 (de) Vorrichtung und verfahren zur vermessung von bauteilen
DE60230186D1 (de) Analysegeräte, biosensoren und verfahren
ATE407370T1 (de) Verfahren und vorrichtung zur seismischen überwachung eines unterirdischen gebiets unter gleichzeitiger verwendung von mehreren vibroseismischen quellen
DE69807042T2 (de) Verfahren zum kalibrieren von sensoren in diagnostischen testverfahren
AU2003232381A8 (en) Method of measuring the movement of an input device
DE60336774D1 (de) System und Verfahren für den automatischen Nachweis der Atemflussbegrenzung
ATE321340T1 (de) Ultrasensitive überwachung von sensoren und prozessen
DE602005006871D1 (de) Verfahren zum Betreiben von Tests von Vibrationsfüllstandssensoren und ein entsprechender Vibrationsfüllstandssensor
DE602004009329D1 (de) Verfahren und system zum selektiven maskieren von testantworten
TWI350992B (en) Method of measuring the movement of an input device
ATE465410T1 (de) Vorrichtungen und verfahren zum nachweis von fruchtwasser in vaginalsekreten
ATE403855T1 (de) Vorrichtung und verfahren zur messung von reibungskräften
ATA1242002A (de) Verfahren und einrichtung zum optischen testen von halbleiterbauelementen
ATE359151T1 (de) Messsystem
DK0990891T3 (da) Fremgangsmåde til inspektion af et gummiprodukt
ATE429399T1 (de) Prüfvorrichtung und zugehöriges verfahren
DE60238082D1 (de) Verfahren und vorrichtung zur messung der geschwindigkeit von chromatographischen impulsen
DE60316876D1 (de) System und Verfahren zur Durchführung von On-Chip-Synchronisierung mittels eines externen Signals
DE50213344D1 (de) Verfahren und Anordnung zum Erfassen und digitalen Übertragen von analogen Ausgangsmessgrössen mehrerer Wandler
DE602004007409D1 (de) Verfahren zum Verbinden mindestens zweier Glieder
ATE442596T1 (de) System und verfahren zur detektion von bewegungen
DE50209215D1 (de) Verfahren zur Dichtigkeitsprüfung von kapazitiven Sensoren
ATE326982T1 (de) Testsystem zur evaluierung der kompatibilität biologisch aktiver substanzen mit copolymeren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition